Evidence map›Paper›PMID 39273127›Full record

ArticleInternational journal of molecular sciences2024

Synergistic Photothermal Therapy and Chemotherapy Enabled by Tumor Microenvironment-Responsive Targeted SWCNT Delivery.

Shuoye Yang, Jiaxin Liu, Huajian Yuan, Qianqian Cheng, Weiwei Shen, Yanteng Lv, Yongmei Xiao, Lu Zhang, Peng Li

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in International journal of molecular sciences, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Review
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Shuoye YangSchool of Biological Engineering, Henan University of Technology, Zhengzhou 450001, China.ORCID 0000-0003-4857-3679
Jiaxin LiuSchool of Biological Engineering, Henan University of Technology, Zhengzhou 450001, China.
Huajian YuanSchool of Biological Engineering, Henan University of Technology, Zhengzhou 450001, China.
Qianqian ChengSchool of Biological Engineering, Henan University of Technology, Zhengzhou 450001, China.
Weiwei ShenSchool of Biological Engineering, Henan University of Technology, Zhengzhou 450001, China.
Yanteng LvSchool of Biological Engineering, Henan University of Technology, Zhengzhou 450001, China.
Yongmei XiaoSchool of Chemistry and Chemical Engineering, Henan University of Technology, Zhengzhou 450001, China.
Lu ZhangSchool of Biological Engineering, Henan University of Technology, Zhengzhou 450001, China.
Peng LiInstitute for Complexity Science, Henan University of Technology, Zhengzhou 450001, China.

Funding

Cultivation Programme for Young Backbone Teachers in Henan University of Technology No: 21420075Foundation for Key Teacher of Colleges and Universities of Henan province No: 2020GGJS090Key R&D and Promotion projects of Henan Province No: 232102310015
6 · The paper itself

Abstract

As a novel therapeutic approach, photothermal therapy (PTT) combined with chemotherapy can synergistically produce antitumor effects. Herein, dithiodipropionic acid (DTDP) was used as a donor of disulfide bonds sensitive to the tumor microenvironment for establishing chemical bonding between the photosensitizer indocyanine green amino (ICG-NH

Indexed as

DoxorubicinNanotubes, CarbonPhotothermal TherapyTumor MicroenvironmentAnimalsAntineoplastic AgentsApoptosisCombined Modality TherapyDrug Delivery SystemsFemaleHumansHyaluronic AcidIndocyanine GreenMCF-7 CellsMiceMice, Inbred BALB CAntineoplastic AgentsDoxorubicinHyaluronic AcidIndocyanine GreenNanotubes, CarbonPhotosensitizing AgentsReactive Oxygen Speciesphotothermal therapySWCNTssynergistic therapytargeted deliverytumor microenvironment response

Identifiers

PMID39273127
PMCPMC11394823

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.